Editor’s Pick: Post Lu177 PSMA options
Topics Discussed
New G4+4 Dx with very low PSA; Tx after Lu177 PSMA fails; immunotherapy with no positive markers vs Jevtana; perineal pain; successful RT to prostate for Mx man; remarkable continued success from abi; interpreting inconsistent scan report; recurrent PCa plateaus w/o treatment; continued success from PARP-I
Chat Log
Jake Hannam (to Everyone): 5:21 PM: Jonathan Epstein 410-955-5043
AnCan Barniskis Room (to Everyone): 5:22 PM: http://pathology.jhu.edu/department/services/secondopinion.cfm
Len (to Everyone): 6:00 PM: Talabostat is an experimental drug that initiates an inflammatory response in the tumor microenvironment, converting cold tumors to hot tumors and thereby making them better targets for checkpoint inhibitors, like pembro or nivolumab. The open-label Phase 2 basket trial is NCT04171219
scott (to Everyone): 6:01 PM: I have to go. I have an online class tonight. Best to everyone. See you next meeting.
Larry Fish (to Everyone): 6:35 PM: there are a number of variations on the ‘perianal abscess leading to lumps and related painful cysts and common and unusual perianal conditions….you can just Google any of the related terms and get to the articles and links that I ran into in my intermittant condition and still looking for a definitive answer or treatment that relolves it permanently. So I use a ring pillow for my chair and it comes and goes.
Joel Blanchette (to Everyone): 6:36 PM: Thanks.